• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

SLC37A2 Polyclonal antibody

SLC37A2 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 20469-1-AP

Synonyms

pp11662, SLC37A2, SPX2, Sugar phosphate exchanger 2

Validation Data Gallery

Filter:
  • Western Blot (WB) analysis of mouse thymus tissue using SLC37A2 Polyclonal antibody (20469-1-AP)

    WB analysis of mouse thymus using 20469-1-AP

    mouse thymus tissue were subjected to SDS PAGE followed by western blot with 20469-1-AP (SLC37A2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

  • Western Blot (WB) analysis of various lysates using SLC37A2 Polyclonal antibody (20469-1-AP)

    WB analysis using 20469-1-AP

    Various lysates were subjected to SDS PAGE followed by western blot with 20469-1-AP (SLC37A2 antibody) at dilution of 1:1500 incubated at room temperature for 1.5 hours.

  • Western Blot (WB) analysis of mouse spleen tissue using SLC37A2 Polyclonal antibody (20469-1-AP)

    WB analysis of mouse spleen using 20469-1-AP

    mouse spleen tissue were subjected to SDS PAGE followed by western blot with 20469-1-AP (SLC37A2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

  • Western Blot (WB) analysis of RAW 264.7 cells using SLC37A2 Polyclonal antibody (20469-1-AP)

    WB analysis of RAW 264.7 using 20469-1-AP

    RAW 264.7 cells were subjected to SDS PAGE followed by western blot with 20469-1-AP (SLC37A2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

Tested Applications

Positive WB detected inmouse thymus tissue, HeLa cells, RAW 264.7 cells, mouse spleen tissue, rat thymus tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:300-1:600
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

20469-1-AP targets SLC37A2 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SLC37A2 fusion protein Ag14306
Full Name solute carrier family 37 (glycerol-3-phosphate transporter), member 2
Calculated Molecular Weight 505 aa, 55 kDa
Observed Molecular Weight 50-75 kDa
GenBank Accession NumberBC051314
Gene Symbol SLC37A2
Gene ID (NCBI) 219855
RRIDAB_10733754
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

The solute carrier family 37 (SLC37) consists of four sugar-phosphate exchangers, A1, A2, A3, and A4, which are anchored in the endoplasmic reticulum (ER) membrane (PMID:23506893). Solute Carrier Family 37 Member 2 (SLC37A2), also knows as SPX2, was firstly identified in a work, conducted on mice and aimed to detect cAMP inducible genes playing a role in promoting cholesterol efflux from the macrophage cell line RAW264 via apoE and apoA1 (PMID:11004510). Interestingly, of the four SLC37A members, SLC37A2 displays the highest level of transcript abundance in neutrophils and macrophages ,indicating that SLC37A2 may play an essential role in regulating innate immune function (PMID:32428862).

Protocols

Product Specific Protocols
WB protocol for SLC37A2 antibody 20469-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols